Ezetimibe 10MG Tablets   3

Background
The Department of Veterans Affairs (VA) and the Department of Defense (DoD) acquire their pharmaceutical requirements through their respective Pharmaceutical Prime Vendor (PPV) Programs. This solicitation aims to establish a supply source that will provide drugs listed in the schedule for purchase through the PPV Programs. The purpose is to ensure availability and consistency of product for nationwide usage and to obtain volume-based, committed-use pricing.

Work Details
The contract is for Ezetimibe 10MG Tablets. The solicitation requires offerors to submit a price for the base year and all four one-year options for line items 1, 2, and 3. Offered prices must not exceed two decimal places and must include a 0.5% Cost Recovery Fee. Offerors must list an 11-digit National Drug Code (NDC) number for each offered drug that is unique to the offeror's company. The solicitation also includes detailed packaging requirements for unit-of-use packaging identified in the Schedule of Supplies, including safety-cap specifications, bottle dimensions, label dimensions, and NDC numbers. The contract will have an Implementation Period and an Ordering Period, with specific timeframes specified in the solicitation.

Period of Performance
The contract will be effective on the date the VA signs the SF-1449 and notifies the offeror of award. The Implementation Period will begin on the Contract Effective Date and end at the start of the Ordering Period. The base year Ordering Period will be in effect for one year.

Place of Performance
Products awarded on this contract will be distributed through Government Prime Vendor contracts, with order placement made by Government Prime Vendor contractors to the awarded contractor.